Friday, June 20, 2025 | 02:05 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

WHO advises doctors against using Gilead's remdesivir for treating Covid-19

The recommendation is a blow to Gilead's drug, which was one of the first thought to offer a meaningful benefit to coronavirus patients after a study showed it reduced their recovery time

remdesivir, coronavirus, drugs, covid, pharma
premium

The antiviral has been used widely to treat Covid and was among the drugs President Donald Trump received when he was diagnosed with the disease in early October

Anna Edney | Bloomberg
The World Health Organization recommended against using Gilead Sciences Inc.’s remdesivir to treat hospitalized Covid-19 patients less than a month after U.S. regulators granted the drug a speedy approval.

“There is currently no evidence that it improves survival or the need for ventilation,” a panel of WHO-convened experts developing Covid-19 treatment guidelines said in The BMJ medical journal.

The recommendation is a blow to Gilead’s drug, which was one of the first thought to offer a meaningful benefit to coronavirus patients after a study showed it reduced their recovery time. 
 
The antiviral has been used widely to treat Covid and